Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 245 entries
Sorted by: Best Match Show Resources per page
Evaluation of Total and Lipid Bound Sialic Acid in Serum in Oral Leukoplakia.

Journal of clinical and diagnostic research : JCDR

Krishnan K, Balasundaram S.
PMID: 28511503
J Clin Diagn Res. 2017 Mar;11(3):ZC25-ZC27. doi: 10.7860/JCDR/2017/16483.9497. Epub 2017 Mar 01.

INTRODUCTION: Oral cancer has become the most common cause of cancer related mortality which may be preceded by oral potentially malignant disorders. Altered glycosylation of glycoconjugates, such as sialic acid are one of the most important molecular changes accompanied...

Cite
Krishnan K, Balasundaram S. Evaluation of Total and Lipid Bound Sialic Acid in Serum in Oral Leukoplakia. J Clin Diagn Res. 2017;11(3):ZC25-ZC27doi: 10.7860/JCDR/2017/16483.9497.
Krishnan, K., & Balasundaram, S. (2017). Evaluation of Total and Lipid Bound Sialic Acid in Serum in Oral Leukoplakia. Journal of clinical and diagnostic research : JCDR, 11(3), ZC25-ZC27. https://doi.org/10.7860/JCDR/2017/16483.9497
Krishnan, Karthik, and Balasundaram, Sivapathasundharam. "Evaluation of Total and Lipid Bound Sialic Acid in Serum in Oral Leukoplakia." Journal of clinical and diagnostic research : JCDR vol. 11,3 (2017): ZC25-ZC27. doi: https://doi.org/10.7860/JCDR/2017/16483.9497
Krishnan K, Balasundaram S. Evaluation of Total and Lipid Bound Sialic Acid in Serum in Oral Leukoplakia. J Clin Diagn Res. 2017 Mar;11(3):ZC25-ZC27. doi: 10.7860/JCDR/2017/16483.9497. Epub 2017 Mar 01. PMID: 28511503; PMCID: PMC5427429.
Copy Download .nbib Format: NLM
Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation.

Frontiers in immunology

Guvench O.
PMID: 26136744
Front Immunol. 2015 Jun 16;6:305. doi: 10.3389/fimmu.2015.00305. eCollection 2015.

The extracellular N-terminal hyaluronan binding domain (HABD) of CD44 is a small globular domain that confers hyaluronan (HA) binding functionality to this large transmembrane glycoprotein. When recombinantly expressed by itself, HABD exists as a globular water-soluble protein that retains...

Cite
Guvench O. Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation. Front Immunol. 2015;6:305doi: 10.3389/fimmu.2015.00305.
Guvench, O. (2015). Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation. Frontiers in immunology, 6305. https://doi.org/10.3389/fimmu.2015.00305
Guvench, Olgun. "Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation." Frontiers in immunology vol. 6 (2015): 305. doi: https://doi.org/10.3389/fimmu.2015.00305
Guvench O. Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation. Front Immunol. 2015 Jun 16;6:305. doi: 10.3389/fimmu.2015.00305. eCollection 2015. PMID: 26136744; PMCID: PMC4468915.
Copy Download .nbib Format: NLM
Erratum to: Mass spectrometric analysis of products of metabolic glycan engineering with azido-modification of sialic acids.

Analytical and bioanalytical chemistry

Bodnar E, Raymond C, Lopez PG, Villacrés C, Butler M, Schoenhofen IC, Durocher Y, Perreault H.
PMID: 26549112
Anal Bioanal Chem. 2015 Dec;407(30):9191-3. doi: 10.1007/s00216-015-9158-4. Epub 2015 Nov 09.

No abstract available.

Cite
Bodnar E, Raymond C, Lopez PG, et al. Erratum to: Mass spectrometric analysis of products of metabolic glycan engineering with azido-modification of sialic acids. Anal Bioanal Chem. 2015;407(30):9191-3doi: 10.1007/s00216-015-9158-4.
Bodnar, E., Raymond, C., Lopez, P. G., Villacrés, C., Butler, M., Schoenhofen, I. C., Durocher, Y., & Perreault, H. (2015). Erratum to: Mass spectrometric analysis of products of metabolic glycan engineering with azido-modification of sialic acids. Analytical and bioanalytical chemistry, 407(30), 9191-3. https://doi.org/10.1007/s00216-015-9158-4
Bodnar, Edward, et al. "Erratum to: Mass spectrometric analysis of products of metabolic glycan engineering with azido-modification of sialic acids." Analytical and bioanalytical chemistry vol. 407,30 (2015): 9191-3. doi: https://doi.org/10.1007/s00216-015-9158-4
Bodnar E, Raymond C, Lopez PG, Villacrés C, Butler M, Schoenhofen IC, Durocher Y, Perreault H. Erratum to: Mass spectrometric analysis of products of metabolic glycan engineering with azido-modification of sialic acids. Anal Bioanal Chem. 2015 Dec;407(30):9191-3. doi: 10.1007/s00216-015-9158-4. Epub 2015 Nov 09. PMID: 26549112.
Copy Download .nbib Format: NLM
Quantifying the Efficiency of .

Journal of carbohydrate chemistry

Zhou Z, Liao G, Stepanovs S, Guo Z.
PMID: 25400325
J Carbohydr Chem. 2014 Nov 01;33(7):395-407. doi: 10.1080/07328303.2014.933483.

A convenient method was developed for the quantification of sialic acids expressed by cells and used to analyze the efficiency of

Cite
Zhou Z, Liao G, Stepanovs S, et al. Quantifying the Efficiency of . J Carbohydr Chem. 2014;33(7):395-407doi: 10.1080/07328303.2014.933483.
Zhou, Z., Liao, G., Stepanovs, S., & Guo, Z. (2014). Quantifying the Efficiency of . Journal of carbohydrate chemistry, 33(7), 395-407. https://doi.org/10.1080/07328303.2014.933483
Zhou, Zhifang, et al. "Quantifying the Efficiency of ." Journal of carbohydrate chemistry vol. 33,7 (2014): 395-407. doi: https://doi.org/10.1080/07328303.2014.933483
Zhou Z, Liao G, Stepanovs S, Guo Z. Quantifying the Efficiency of . J Carbohydr Chem. 2014 Nov 01;33(7):395-407. doi: 10.1080/07328303.2014.933483. PMID: 25400325; PMCID: PMC4228960.
Copy Download .nbib Format: NLM
Screening of Neu5Acα(2-6)gal isomer preferences of siglecs with a sialic acid microarray.

Organic & biomolecular chemistry

Yadav R, Leviatan Ben-Arye S, Subramani B, Padler-Karavani V, Kikkeri R.
PMID: 27714250
Org Biomol Chem. 2016 Nov 22;14(46):10812-10815. doi: 10.1039/c6ob01688j.

Sialic acids (Sias) are important terminal sugars on cell surfaces involved in a wide range of protein-carbohydrate interactions. Hence, agents modulating sias-mediated protein interactions are promising inhibitors or vaccine candidates. Here, we report the synthesis of Neu5Acα(2-6)Gal structural analogs...

Cite
Yadav R, Leviatan Ben-Arye S, Subramani B, et al. Screening of Neu5Acα(2-6)gal isomer preferences of siglecs with a sialic acid microarray. Org Biomol Chem. 2016;14(46):10812-10815doi: 10.1039/c6ob01688j.
Yadav, R., Leviatan Ben-Arye, S., Subramani, B., Padler-Karavani, V., & Kikkeri, R. (2016). Screening of Neu5Acα(2-6)gal isomer preferences of siglecs with a sialic acid microarray. Organic & biomolecular chemistry, 14(46), 10812-10815. https://doi.org/10.1039/c6ob01688j
Yadav, Rohan, et al. "Screening of Neu5Acα(2-6)gal isomer preferences of siglecs with a sialic acid microarray." Organic & biomolecular chemistry vol. 14,46 (2016): 10812-10815. doi: https://doi.org/10.1039/c6ob01688j
Yadav R, Leviatan Ben-Arye S, Subramani B, Padler-Karavani V, Kikkeri R. Screening of Neu5Acα(2-6)gal isomer preferences of siglecs with a sialic acid microarray. Org Biomol Chem. 2016 Nov 22;14(46):10812-10815. doi: 10.1039/c6ob01688j. PMID: 27714250.
Copy Download .nbib Format: NLM
Multifaceted Role of Sialylation in Prion Diseases.

Frontiers in neuroscience

Baskakov IV, Katorcha E.
PMID: 27551257
Front Neurosci. 2016 Aug 08;10:358. doi: 10.3389/fnins.2016.00358. eCollection 2016.

Mammalian prion or PrP(Sc) is a proteinaceous infectious agent that consists of a misfolded, self-replicating state of a sialoglycoprotein called the prion protein, or PrP(C). Sialylation of the prion protein N-linked glycans was discovered more than 30 years ago,...

Cite
Baskakov IV, Katorcha E. Multifaceted Role of Sialylation in Prion Diseases. Front Neurosci. 2016;10:358doi: 10.3389/fnins.2016.00358.
Baskakov, I. V., & Katorcha, E. (2016). Multifaceted Role of Sialylation in Prion Diseases. Frontiers in neuroscience, 10358. https://doi.org/10.3389/fnins.2016.00358
Baskakov, Ilia V, and Katorcha, Elizaveta. "Multifaceted Role of Sialylation in Prion Diseases." Frontiers in neuroscience vol. 10 (2016): 358. doi: https://doi.org/10.3389/fnins.2016.00358
Baskakov IV, Katorcha E. Multifaceted Role of Sialylation in Prion Diseases. Front Neurosci. 2016 Aug 08;10:358. doi: 10.3389/fnins.2016.00358. eCollection 2016. PMID: 27551257; PMCID: PMC4976111.
Copy Download .nbib Format: NLM
Regulated lysosomal exocytosis mediates cancer progression.

Science advances

Machado E, White-Gilbertson S, van de Vlekkert D, Janke L, Moshiach S, Campos Y, Finkelstein D, Gomero E, Mosca R, Qiu X, Morton CL, Annunziata I, d'Azzo A.
PMID: 26824057
Sci Adv. 2015 Dec 18;1(11):e1500603. doi: 10.1126/sciadv.1500603. eCollection 2015 Dec.

Understanding how tumor cells transition to an invasive and drug-resistant phenotype is central to cancer biology, but the mechanisms underlying this transition remain unclear. We show that sarcomas gain these malignant traits by inducing lysosomal exocytosis, a ubiquitous physiological...

Cite
Machado E, White-Gilbertson S, van de Vlekkert D, et al. Regulated lysosomal exocytosis mediates cancer progression. Sci Adv. 2015;1(11):e1500603doi: 10.1126/sciadv.1500603.
Machado, E., White-Gilbertson, S., van de Vlekkert, D., Janke, L., Moshiach, S., Campos, Y., Finkelstein, D., Gomero, E., Mosca, R., Qiu, X., Morton, C. L., Annunziata, I., & d'Azzo, A. (2015). Regulated lysosomal exocytosis mediates cancer progression. Science advances, 1(11), e1500603. https://doi.org/10.1126/sciadv.1500603
Machado, Eda, et al. "Regulated lysosomal exocytosis mediates cancer progression." Science advances vol. 1,11 (2015): e1500603. doi: https://doi.org/10.1126/sciadv.1500603
Machado E, White-Gilbertson S, van de Vlekkert D, Janke L, Moshiach S, Campos Y, Finkelstein D, Gomero E, Mosca R, Qiu X, Morton CL, Annunziata I, d'Azzo A. Regulated lysosomal exocytosis mediates cancer progression. Sci Adv. 2015 Dec 18;1(11):e1500603. doi: 10.1126/sciadv.1500603. eCollection 2015 Dec. PMID: 26824057; PMCID: PMC4730843.
Copy Download .nbib Format: NLM
Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation.

The open respiratory medicine journal

Dosanjh A, Muchmore EA.
PMID: 19572026
Open Respir Med J. 2009 May 18;3:79-84. doi: 10.2174/1874306400903010079.

Chronic colonization and infection of the lung with Pseudomonas aeruginosa is a major cause of morbidity and mortality in cystic fibrosis (CF) patients. Imundo, et al. determined that CF cells had a higher concentration of an asialoganglioside (asialo-G(M1)), to...

Cite
Dosanjh A, Muchmore EA. Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation. Open Respir Med J. 2009;3:79-84doi: 10.2174/1874306400903010079.
Dosanjh, A., & Muchmore, E. A. (2009). Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation. The open respiratory medicine journal, 379-84. https://doi.org/10.2174/1874306400903010079
Dosanjh, Amrita, and Muchmore, Elaine A. "Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation." The open respiratory medicine journal vol. 3 (2009): 79-84. doi: https://doi.org/10.2174/1874306400903010079
Dosanjh A, Muchmore EA. Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation. Open Respir Med J. 2009 May 18;3:79-84. doi: 10.2174/1874306400903010079. PMID: 19572026; PMCID: PMC2703207.
Copy Download .nbib Format: NLM
The Relationship Between Lipid Peroxidation and LDL Desialylation in Experimental Atherosclerosis.

Toxicology mechanisms and methods

Oztürk Z, Sönmez H, Görgün FM, Ekmekçi H, Bilgen D, Ozen N, Sözer V, Altuğ T, Kökoğlu E.
PMID: 20020949
Toxicol Mech Methods. 2007;17(5):265-73. doi: 10.1080/15376510600992608.

ABSTRACT High serum total cholesterol concentration has been strongly connected with atherosclerosis in numerous studies. Being the main carrier of cholesterol in blood, low-density lipoprotein (LDL) is also the principal lipoprotein causing atherosclerosis. Sialic acids are a family of...

Cite
Oztürk Z, Sönmez H, Görgün FM, et al. The Relationship Between Lipid Peroxidation and LDL Desialylation in Experimental Atherosclerosis. Toxicol Mech Methods. 2007;17(5):265-73doi: 10.1080/15376510600992608.
Oztürk, Z., Sönmez, H., Görgün, F. M., Ekmekçi, H., Bilgen, D., Ozen, N., Sözer, V., Altuğ, T., & Kökoğlu, E. (2007). The Relationship Between Lipid Peroxidation and LDL Desialylation in Experimental Atherosclerosis. Toxicology mechanisms and methods, 17(5), 265-73. https://doi.org/10.1080/15376510600992608
Oztürk, Zeynep, et al. "The Relationship Between Lipid Peroxidation and LDL Desialylation in Experimental Atherosclerosis." Toxicology mechanisms and methods vol. 17,5 (2007): 265-73. doi: https://doi.org/10.1080/15376510600992608
Oztürk Z, Sönmez H, Görgün FM, Ekmekçi H, Bilgen D, Ozen N, Sözer V, Altuğ T, Kökoğlu E. The Relationship Between Lipid Peroxidation and LDL Desialylation in Experimental Atherosclerosis. Toxicol Mech Methods. 2007;17(5):265-73. doi: 10.1080/15376510600992608. PMID: 20020949.
Copy Download .nbib Format: NLM
Blot analysis with lectins for the evaluation of glycoproteins in cultured cells and tissues.

Methods in molecular medicine

Zuber C, Li WP, Roth J.
PMID: 21374457
Methods Mol Med. 1998;9:159-66. doi: 10.1385/0-89603-396-1:159.

The carbohydrate-binding properties of plant and animal lectins have found many diverse applications in biomedical research that are comprehensively treated in the various chapters of this book. In our studies, lectins are often applied for the in situ detection...

Cite
Zuber C, Li WP, Roth J. Blot analysis with lectins for the evaluation of glycoproteins in cultured cells and tissues. Methods Mol Med. 1998;9:159-66doi: 10.1385/0-89603-396-1:159.
Zuber, C., Li, W. P., & Roth, J. (1998). Blot analysis with lectins for the evaluation of glycoproteins in cultured cells and tissues. Methods in molecular medicine, 9159-66. https://doi.org/10.1385/0-89603-396-1:159
Zuber, C, et al. "Blot analysis with lectins for the evaluation of glycoproteins in cultured cells and tissues." Methods in molecular medicine vol. 9 (1998): 159-66. doi: https://doi.org/10.1385/0-89603-396-1:159
Zuber C, Li WP, Roth J. Blot analysis with lectins for the evaluation of glycoproteins in cultured cells and tissues. Methods Mol Med. 1998;9:159-66. doi: 10.1385/0-89603-396-1:159. PMID: 21374457.
Copy Download .nbib Format: NLM
Catalytic preference of Salmonella typhimurium LT2 sialidase for N-acetylneuraminic acid residues over N-glycolylneuraminic acid residues.

FEBS open bio

Minami A, Ishibashi S, Ikeda K, Ishitsubo E, Hori T, Tokiwa H, Taguchi R, Ieno D, Otsubo T, Matsuda Y, Sai S, Inada M, Suzuki T.
PMID: 23772399
FEBS Open Bio. 2013 May 29;3:231-6. doi: 10.1016/j.fob.2013.05.002. Print 2013.

In a comparison of sialidase activities toward N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), we found that Salmonella typhimurium LT2 sialidase (STSA) hardly cleaved 4-methylumbelliferyl Neu5Gc (4MU-Neu5Gc). The k cat/K m value of STSA for 4MU-Neu5Gc was found to...

Cite
Minami A, Ishibashi S, Ikeda K, et al. Catalytic preference of Salmonella typhimurium LT2 sialidase for N-acetylneuraminic acid residues over N-glycolylneuraminic acid residues. FEBS Open Bio. 2013;3:231-6doi: 10.1016/j.fob.2013.05.002.
Minami, A., Ishibashi, S., Ikeda, K., Ishitsubo, E., Hori, T., Tokiwa, H., Taguchi, R., Ieno, D., Otsubo, T., Matsuda, Y., Sai, S., Inada, M., & Suzuki, T. (2013). Catalytic preference of Salmonella typhimurium LT2 sialidase for N-acetylneuraminic acid residues over N-glycolylneuraminic acid residues. FEBS open bio, 3231-6. https://doi.org/10.1016/j.fob.2013.05.002
Minami, Akira, et al. "Catalytic preference of Salmonella typhimurium LT2 sialidase for N-acetylneuraminic acid residues over N-glycolylneuraminic acid residues." FEBS open bio vol. 3 (2013): 231-6. doi: https://doi.org/10.1016/j.fob.2013.05.002
Minami A, Ishibashi S, Ikeda K, Ishitsubo E, Hori T, Tokiwa H, Taguchi R, Ieno D, Otsubo T, Matsuda Y, Sai S, Inada M, Suzuki T. Catalytic preference of Salmonella typhimurium LT2 sialidase for N-acetylneuraminic acid residues over N-glycolylneuraminic acid residues. FEBS Open Bio. 2013 May 29;3:231-6. doi: 10.1016/j.fob.2013.05.002. Print 2013. PMID: 23772399; PMCID: PMC3678298.
Copy Download .nbib Format: NLM
Molecular Dynamics of Sialic Acid Analogues and their Interaction with Influenza Hemagglutinin.

Indian journal of pharmaceutical sciences

Blessia TF, Rapheal VS, Sharmila DJ.
PMID: 21218055
Indian J Pharm Sci. 2010 Jul;72(4):449-57. doi: 10.4103/0250-474X.73919.

Synthetic sialic acid analogues with multiple modifications at different positions(C-1/C-2/C-4/C-8/C-9) are investigated by molecular mechanics and molecular dynamics to determine their conformational preferences and structural stability to interact with their natural receptors. Sialic acids with multiple modifications are soaked...

Cite
Blessia TF, Rapheal VS, Sharmila DJ. Molecular Dynamics of Sialic Acid Analogues and their Interaction with Influenza Hemagglutinin. Indian J Pharm Sci. 2010;72(4):449-57doi: 10.4103/0250-474X.73919.
Blessia, T. F., Rapheal, V. S., & Sharmila, D. J. (2010). Molecular Dynamics of Sialic Acid Analogues and their Interaction with Influenza Hemagglutinin. Indian journal of pharmaceutical sciences, 72(4), 449-57. https://doi.org/10.4103/0250-474X.73919
Blessia, T Femlin, et al. "Molecular Dynamics of Sialic Acid Analogues and their Interaction with Influenza Hemagglutinin." Indian journal of pharmaceutical sciences vol. 72,4 (2010): 449-57. doi: https://doi.org/10.4103/0250-474X.73919
Blessia TF, Rapheal VS, Sharmila DJ. Molecular Dynamics of Sialic Acid Analogues and their Interaction with Influenza Hemagglutinin. Indian J Pharm Sci. 2010 Jul;72(4):449-57. doi: 10.4103/0250-474X.73919. PMID: 21218055; PMCID: PMC3013563.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 245 entries